Cardiovascular Research Advance Access [Accepted Manuscript] published online on April 22, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn098
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Spotlight issue on Signaling in Cardiac Metabolism: Transcriptional control of mitochondrial biogenesis. The central role of PGC-1
INSERM, U-769, F-92296 Châtenay-Malabry, France; Univ Paris-Sud, IFR141, F-92296 Châtenay-Malabry, France
Address for correspondence: Dr Renée Ventura-Clapier U-769 INSERM Faculté de Pharmacie, Université Paris-Sud5 rue J-B Clément 92296 Châtenay-Malabry France Tel: (33-1) 46.83.57.62. Fax: (33-1) 46.83.54.75. E-mail: renee.ventura{at}u-psud.fr
Although the concept of energy starvation in the failing heart was proposed decades ago, still very little is known about the origin of energetic failure. Recent advances in molecular biology have started to elucidate the transcriptional events governing mitochondrial biogenesis. In particular a great step forwards was taken with the discovery that peroxisome proliferator-activated receptor gamma co-activator (PGC-1
) is the master regulator of mitochondrial biogenesis. The molecular mechanisms underlying the downregulation of PGC-1
and the consequent decrease in mitochondrial function in heart failure are, however, still poorly understood. Indeed, the main pathways involved in mitochondrial biogenesis are thought to be up- rather than down-regulated in pathological hypertrophy and heart failure. The current review summarizes recent advances in this field and is restricted to the heart when cardiac data is available.
Time for primary review: 31 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Fisslthaler and I. Fleming Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells Circ. Res., July 17, 2009; 105(2): 114 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ingwall On the Control of Metabolic Remodeling in Mitochondria of the Failing Heart Circ Heart Fail, July 1, 2009; 2(4): 275 - 277. [Full Text] [PDF] |
||||
![]() |
A. Garnier, J. Zoll, D. Fortin, B. N'Guessan, F. Lefebvre, B. Geny, B. Mettauer, V. Veksler, and R. Ventura-Clapier Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II Circ Heart Fail, July 1, 2009; 2(4): 342 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Palomer, D. Alvarez-Guardia, R. Rodriguez-Calvo, T. Coll, J. C. Laguna, M. M. Davidson, T. O. Chan, A. M. Feldman, and M. Vazquez-Carrera TNF-{alpha} reduces PGC-1{alpha} expression through NF-{kappa}B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc Res, March 1, 2009; 81(4): 703 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ingwall Energy metabolism in heart failure and remodelling Cardiovasc Res, February 15, 2009; 81(3): 412 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Lopaschuk and D. P. Kelly Signalling in cardiac metabolism Cardiovasc Res, July 15, 2008; 79(2): 205 - 207. [Full Text] [PDF] |
||||


